Pharmafile Logo
Pharmafocus logo
Advanced Search

Wainwright Associates; EMA; Pharmacovigilance; PV

Showing 3 posts of 3 posts found.

EMA request feedback on the draft EU reference dates

April 19, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates; EMA; Pharmacovigilance; PV

The European Medicines Agency has invited marketing-authorisation holders and other stakeholders to review and provide comments on the draft list …

News
Press release

Updated set of mandatory Article 57(2) requirements for marketing authorisation holders

March 15, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates; EMA; Pharmacovigilance; PV

An updated set of mandatory requirements for Marketing Authorisation Holders (MAH) to comply with Article 57(2) of the forthcoming new …

News
Press release

Good Pharmacovigilance Practice modules released by European Medicine Agency

March 1, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates; EMA; Pharmacovigilance; PV

The European Medicines Agency has now released drafts of the first seven Good Pharmacovigilance Practice (GPvP) Modules for public consultation.  …

News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025